It is not yet clear if Diageo Plc is looking to sell its complete stake in RCB.
Pharma tycoon Adar Poonawalla has emerged as a potential suitor for the Indian Premier League franchise Royal Challengers Bengaluru, sparking fresh speculation around a possible change in ownership of one of the league's most high-profile teams.
Homebound missed an Oscar nomination; Sinners broke the record by getting the most nominations ever, at 16 counts.
'Established filmmakers want to go with the sequels of earlier hit films like Housefull 5 or Mastiii 4. They don't want to come up with fresh ideas. This is pure laziness.'
Indian corporates collectively raised over Rs 17,500 crore from the domestic debt capital market through bond issuances on Tuesday. The issuances were led by Bharti Telecom's Rs 10,500 crore fundraise in two tranches, the largest by an Indian company in the domestic market so far in FY26.
'We have just scratched the surface because cricket has been around for the longest time.'
Poonawalla has been getting threats from various groups regarding the COVID-19 vaccine supplies.
Apart from making efforts to meet the requirements of India, the company is also trying its best to balance the needs of the rest of the world, he added.
What the UK is getting out of the Serum Institute is what India is losing. And the responsibility of the Indian State ought to have been to dictate where Serum Institute's vaccine doses should go, argues Ambassador M K Bhadrakumar.
Poonawalla wished the country and Prime Minister Narendra Modi success for the vaccination programme.
Poonawalla, who is in London, however, noted that the company is making every effort to enhance production of Covishield amid the second wave of COVID in the country.
On production capacity of Covishield, the vaccine being manufactured and supplied by Serum in India under a licensing agreement with Oxford and AstraZeneca, he said the present capacity is 130 million doses per month and always try to increase it further.
'It was unfair to expect him to continue to keep on supplying vaccines without being given a firm commitment or a financial grant of any sort.'
Janhvi Kapoor, Ishaan Khatter, along with others, turned heads at Cannes 2025 as they walked the red carpet in absolute style ahead of the much-awaited premiere of their film 'Homebound' at the prestigious film festival.
More screens, more films, and longer windows will convert to more people watching, assuming they know a film is releasing, points out Vanita Kohli-Khandekar.
'Salman's bad phase is going on for the last five-six years.'
Manish Malhotra's Diwali Party had the who's who of Bollywood in attendance.
Businessmen from all over the world attended Radhika Merchant and Anant Ambani's wedding at the Jio World Convention Centre, Bandra Kurla Complex, north west Mumbai, on Friday, July 12, 2024.
Industry experts believe that this deal will positively impact the Indian film industry, which is struggling with fewer movie releases.
A non-strategic investor like Poonawalla brings in not only capital but also creative freedom. Indian cinema needs more investors like him, reports Vanita Kohli Khandekar.
Siddharth Roy Kapur's RKF aims to raise around $50 million by offering up to a 50 per cent stake in the company.
Business tycoons at the Ambani's pre-wedding celebrations at Jamnagar, Gujarat.
The Bombay high court on Monday said content posted by two individuals and their organisations against vaccine manufacturing major Serum Institute of India (SII) was "prima facie defamatory" and directed them to delete it.
'I understand some people are comfortable getting a Covishield shot as their third dose.'
'What is Balaji without Ekta (Kapoor), what is Dharma without Karan (Johar?)'
Serum CEO Adar Poonawalla posted a video of him playing tennis, with a message for the unvaccinated Novak Djokovic.
Billionaire Mukesh Ambani's Reliance Industries and Tata Group have made it to the prestigious TIME's list of 100 World's Most Influential Companies of 2024. TIME called Reliance 'India's Juggernaut'. This is the second time that Reliance has found its way into the TIME list. Jio Platforms, the firm that holds digital properties of the conglomerate, was included in the inaugural TIME 100 Most Influential Companies List of 2021. Serum Institute is the other Indian company on the list.
Poonawalla was talking to media persons amid rising cases of coronavirus infections in the country since March.
IT major HCL Technologies' Shiv Nadar has retained his position as the 'most generous Indian' in 2023 as well, with a 76 per cent jump in his donations at Rs 2,042 crore. Wipro's Azim Premji's donations zoomed by 267 per cent to Rs 1,774 crore during the same year, according to the Edelgive Hurun India Philanthropy List 2023 released on Thursday. Richest Indian Mukesh Ambani donated Rs 376 crore in the year, which is an 8 per cent decline.
Serum Institute of India chief Adar Poonawalla will pay 138 million (about Rs 1,444 crore) for a Mayfair mansion in London in one of the city's most expensive home sales of the year
An FIR was launched against some unidentified persons for cheating the SII for more than Rs 1 crore, said the officials on Sunday.
Sachin Tendulkar has recently made an equity investment of $2 million in digital entertainment and technology company JetSynthesys. The investment further strengthens Tendulkar's relationship with JetSynthesys, as the two already have an existing joint venture for a digital destination for all things cricket, called 100MB, and immersive cricket games Sachin Saga Cricket Champions and Sachin Saga VR. With this investment, Tendulkar joins the bandwagon of existing shareholders of JetSynthesys, who include Adar Poonawalla, Kris Gopalakrishnan, and the multi-billion-dollar family offices of the promoters of Thermax, Triveni Group, Yohan Poonawalla Group and DSP Group.
Covovax is likely to be available on the portal in a few days at a price of Rs 225 per dose plus applicable GST.
"I realise that a lot of Indians who have taken Covishield are facing issues with travel to the EU, I assure everyone, I have taken this up at the highest levels and hope to resolve this matter soon, both with regulators and at a diplomatic level with countries," Poonawalla said in a tweet.
This is Kareena's first appearance after she gave birth to her second son on February 21.
The development comes after requests for indemnity and exemption from bridging trials have been made by Pfizer and Moderna to the Indian government.
The PM's visit would signal a strong intent towards making sure India becomes a beneficiary as vaccines become a massively traded commodity in the coming years.
Poonawalla said booster vaccines have no demand as there is general lethargy among people and also because they are fed up with the pandemic.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances